IXICO (LON:IXI) Trading 14% Higher – Still a Buy?

IXICO plc (LON:IXI) traded up 14% during trading on Tuesday . The stock traded as high as GBX 7.50 and last traded at GBX 7.50. 197,515 shares changed hands during mid-day trading, an increase of 50% from the average session volume of 131,852 shares. The stock had previously closed at GBX 6.58.

IXICO Trading Up 5.9%

The firm has a market cap of £19.62 million, a P/E ratio of -4.86, a PEG ratio of -0.38 and a beta of 0.07. The company has a 50 day moving average of GBX 7.37 and a 200 day moving average of GBX 9.44. The company has a debt-to-equity ratio of 1.53, a quick ratio of 4.90 and a current ratio of 3.03.

IXICO (LON:IXI) last announced its quarterly earnings results on Tuesday, May 19th. The company reported GBX (1.21) EPS for the quarter. The firm had revenue of GBX 395 million during the quarter. IXICO had a negative net margin of 25.27% and a negative return on equity of 13.74%. Analysts predict that IXICO plc will post -289.3584879 EPS for the current fiscal year.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.